Metformin Prevents DMH-induced Colorectal Cancer in Diabetic Rats by Reversing the Warburg Effect

Overview

Journal Cancer Med

Specialty Oncology

Date 2015 Sep 18

PMID 26376762

Citations 20

Authors

Yanglei Jia

Zengyi Ma

Xiaofei Liu

Wenjing Zhou

Shan He

Xia Xu

Guijie Ren

Gang Xu

Keli Tian

Affiliations

Soon will be listed here.

Abstract

Epidemiologic studies have shown that the treatment of diabetics with metformin reduced the risk of cancer-related mortality. Here, we investigated the chemopreventive effects of metformin on dimethylhydrazine (DMH)-induced colorectal carcinogenesis in diabetic SD rats following metformin treatment and the effect on Warburg effect involved in this process. Diabetic rat models were induced with high-fat feeding in combination with a low dose of Streptozotocin (STZ) and then induce colorectal cancer with a low dose of DMH. The formation of colorectal Aberrant crypt foci (ACF) and the incidence, number and size of the tumor were measured. The proliferation indices of colonic tissues were determined through Proliferating cell nuclear antigen (PCNA) immunostaining. Then detect the expression of PK and IDH in colonic tissues using immunohistochemistry and Western blot. The enzyme activities of HK and PDH in colonic tissues were measured. The growth and expression of PK and IDH and activity of HK and PDH in cell lines LoVo and HT-29 were measured after metformin treatment. The results showed that metformin treatment significantly inhibited the formation of ACF and tumors. The proliferation index of colonic tissues was significantly decreased following metformin treatment. In addition, metformin inhibited cell growth and decreased the imbalance in the expression of the enzymes involved in glycolysis and the TCA cycle. These findings suggested that metformin might produce a synergistic colon cancer-preventative effect in diabetic patients through the regulation of the enzymes expression involved in glucose metabolism.

Citing Articles

Colorectal Cancer: Pathogenesis and Targeted Therapy.

Li J, Pan J, Wang L, Ji G, Dang Y MedComm (2020). 2025; 6(3):e70127.

PMID: 40060193 PMC: 11885891. DOI: 10.1002/mco2.70127.

Metformin's role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study.

Lawler T, Walts Z, Giurini L, Steinwandel M, Lipworth L, Murff H Cancer Epidemiol. 2024; 90:102566.

PMID: 38518387 PMC: 11108092. DOI: 10.1016/j.canep.2024.102566.

Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics.

Pal S, Sharma A, Padalumavunkal Mathew S, Jaganathan B Front Immunol. 2023; 13:955476.

PMID: 36618350 PMC: 9815821. DOI: 10.3389/fimmu.2022.955476.

Metabolism and Colorectal Cancer.

Sedlak J, Yilmaz O, Roper J Annu Rev Pathol. 2022; 18:467-492.

PMID: 36323004 PMC: 9877174. DOI: 10.1146/annurev-pathmechdis-031521-041113.

Antioxidant and Anticancer Potentials of the Olive and Sesame Mixture against Dimethylhydrazine-Induced Colorectal Cancer in Wistar Rats.

Valaei A, Azadeh F, Mostafavi Niaki S, Salehi A, Shakib Khoob M, Mirebrahimi S Biomed Res Int. 2022; 2022:5440773.

PMID: 36262974 PMC: 9576397. DOI: 10.1155/2022/5440773.

References

Ye J, Mancuso A, Tong X, Ward P, Fan J, Rabinowitz J . Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci U S A. 2012; 109(18):6904-9. PMC: 3345000. DOI: 10.1073/pnas.1204176109. View

Whiteley L, Hudson Jr L, Pretlow T . Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen. Toxicol Pathol. 1996; 24(6):681-9. DOI: 10.1177/019262339602400602. View

Li W, Xiao M, Zhang D, Yu D, Yang R, Li X . Mutation and expression analysis of the IDH1, IDH2, DNMT3A, and MYD88 genes in colorectal cancer. Gene. 2014; 546(2):263-70. DOI: 10.1016/j.gene.2014.05.070. View

Ko C, Chaudhry S . The need for a multidisciplinary approach to cancer care. J Surg Res. 2002; 105(1):53-7. DOI: 10.1006/jsre.2002.6449. View

Lv Q, Xing S, Li Z, Li J, Gong P, Xu X . Altered expression levels of IDH2 are involved in the development of colon cancer. Exp Ther Med. 2012; 4(5):801-806. PMC: 3493704. DOI: 10.3892/etm.2012.676. View

Rodrigues M, Silva L, Salvadori D, de Camargo J, MONTENEGRO M . Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz J Med Biol Res. 2002; 35(3):351-5. DOI: 10.1590/s0100-879x2002000300010. View

Jiang Y, Ben Q, Shen H, Lu W, Zhang Y, Zhu J . Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2011; 26(11):863-76. DOI: 10.1007/s10654-011-9617-y. View

Reagan-Shaw S, Nihal M, Ahmad N . Dose translation from animal to human studies revisited. FASEB J. 2007; 22(3):659-61. DOI: 10.1096/fj.07-9574LSF. View

Madiraju A, Erion D, Rahimi Y, Zhang X, Braddock D, Albright R . Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014; 510(7506):542-6. PMC: 4074244. DOI: 10.1038/nature13270. View

10.

Mazurek S, Boschek C, Hugo F, Eigenbrodt E . Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol. 2005; 15(4):300-8. DOI: 10.1016/j.semcancer.2005.04.009. View

11.

Xu G, Ren G, Xu X, Yuan H, Wang Z, Kang L . Combination of curcumin and green tea catechins prevents dimethylhydrazine-induced colon carcinogenesis. Food Chem Toxicol. 2009; 48(1):390-5. DOI: 10.1016/j.fct.2009.10.027. View

12.

Deng L, Gui Z, Zhao L, Wang J, Shen L . Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci. 2012; 57(6):1576-85. DOI: 10.1007/s10620-012-2055-1. View

13.

WEINHOUSE S . On respiratory impairment in cancer cells. Science. 1956; 124(3215):267-9. DOI: 10.1126/science.124.3215.267. View

14.

Furukawa F, Nishikawa A, Kitahori Y, Tanakamaru Z, Hirose M . Spontaneous development of aberrant crypt foci in F344 rats. J Exp Clin Cancer Res. 2002; 21(2):197-201. View

15.

Collier C, Bruce C, Smith A, Lopaschuk G, Dyck D . Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. Am J Physiol Endocrinol Metab. 2006; 291(1):E182-9. DOI: 10.1152/ajpendo.00272.2005. View

16.

Tolle S, Dyson R, NEWBURGH R, Cardenas J . Pyruvate kinase isozymes in neurons, glia, neuroblastoma, and glioblastoma. J Neurochem. 1976; 27(6):1355-60. DOI: 10.1111/j.1471-4159.1976.tb02615.x. View

17.

Siegel R, DeSantis C, Jemal A . Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):104-17. DOI: 10.3322/caac.21220. View

18.

Kirpichnikov D, McFarlane S, Sowers J . Metformin: an update. Ann Intern Med. 2002; 137(1):25-33. DOI: 10.7326/0003-4819-137-1-200207020-00009. View

19.

Burcelin R . The antidiabetic gutsy role of metformin uncovered?. Gut. 2013; 63(5):706-7. DOI: 10.1136/gutjnl-2013-305370. View

20.

Robbins D, Wittwer J, Codarin S, Circu M, Aw T, Huang T . Isocitrate dehydrogenase 1 is downregulated during early skin tumorigenesis which can be inhibited by overexpression of manganese superoxide dismutase. Cancer Sci. 2012; 103(8):1429-33. PMC: 3407305. DOI: 10.1111/j.1349-7006.2012.02317.x. View